Glen Eagle Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Glen Eagle Advisors, LLC

$546 Billion
Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 136 shares of REGN stock, worth $112,129. This represents 0.03% of its overall portfolio holdings.

Number of Shares

136

Previous 45 202.22%

Holding current value

$112,129

Previous $15.5 Million 822.43%

% of portfolio

0.03%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $80,371 - $97,478	91 Added 202.22%	136 $143 Million
Q1 2024 Jul 03, 2024	BUY	$902.69 - $993.35 $113,738 - $125,162	126 New	126 $121 Million
Q1 2023 Aug 13, 2024	SELL	$680.49 - $826.97 $680 - $826	-1 Reduced 0.78%	128 $105 Million
Q4 2022 Aug 13, 2024	BUY	$705.89 - $766.39 $705 - $766	1 Added 0.78%	129 $93.1 Million
Q3 2022 Aug 13, 2024	SELL	$573.97 - $724.32 $4,591 - $5,794	-8 Reduced 5.88%	128 $88.2 Million
Q3 2021 Aug 13, 2024	SELL	$574.03 - $680.96 $2,870 - $3,404	-5 Reduced 3.55%	136 $82.3 Million
Q2 2021 Aug 13, 2024	SELL	$472.8 - $558.54 $28,368 - $33,512	-60 Reduced 29.85%	141 $78.8 Million
Q1 2021 Aug 13, 2024	SELL	$446.73 - $548.2 $22,336 - $27,410	-50 Reduced 19.92%	201 $95.1 Million
Q4 2020 Aug 13, 2024	BUY	$478.3 - $607.98 $59,787 - $75,997	125 Added 99.21%	251 $121 Million
Q2 2020 Aug 13, 2024	BUY	$493.32 - $643.92 $53,278 - $69,543	108 Added 71.05%	260 $162 Million
Q1 2020 Aug 13, 2024	BUY	$336.18 - $494.43 $35,971 - $52,904	107 Added 237.78%	152 $74.2 Million
Q1 2019 Aug 13, 2024	SELL	$372.08 - $439.57 $30,138 - $35,605	-81 Reduced 64.29%	45 $18.5 Million
Q2 2018 Aug 13, 2024	SELL	$284.6 - $344.99 $4.4 Million - $5.33 Million	-15,451 Reduced 99.71%	45 $15.5 Million
Q1 2018 Aug 14, 2024	SELL	$315.82 - $393.78 $25,581 - $31,896	-81 Reduced 64.29%	45 $15.5 Million
Q1 2018 Aug 13, 2024	BUY	$315.82 - $393.78 $4.88 Million - $6.08 Million	15,451 Added 34335.56%	15,496 $15.5 Million
Q3 2017 Aug 13, 2024	SELL	$431.38 - $504.0 $34,941 - $40,824	-81 Reduced 64.29%	45 $20.1 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-81	45 $16.5 Million

Others Institutions Holding REGN

# of Institutions

1,492

Shares Held

85.8M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History